Alveolar Soft Part SarcomaSymptoms, Doctors, Treatments, Advances & More
Learn About Alveolar Soft Part Sarcoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Piotr Rutkowski practices practicing medicine in Krakow, Poland. Mr. Rutkowski is rated as an Elite expert by MediFind in the treatment of Alveolar Soft Part Sarcoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Melanoma, Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Lymphadenectomy, and Pancreaticoduodenectomy.
Orthopaedics Clinic At Lauritzen Outpatient Center
Sean Mcgarry is an Orthopedics provider practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 28 years. Dr. Mcgarry is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Osteosarcoma, Myxoid Liposarcoma, and Hip Replacement.
Aurora Orthopedics
Nicholas Webber is an Orthopedics provider practicing medicine in Milwaukee, Wisconsin. Dr. Webber is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Osteoarthritis, Osteonecrosis, Rhabdomyosarcoma Embryonal, Hip Replacement, and Knee Replacement. Dr. Webber is board certified in American Board Of Orthopaedic Surgery.
Background: A type of drug called monoclonal antibody immune checkpoint inhibitors are often used in cancer treatment. These drugs help the body s immune system fight cancer by blocking proteins that cause cancer cells to grow. One of these drugs (atezolizumab) is approved to treat certain cancers. Researchers want to find out if lower doses of this drug might provide the same benefit with fewer adverse effec...
Summary: This phase II trial tests whether atezolizumab in combination with selinexor works to shrink tumors in patients with alveolar soft part sarcoma and whether the study drugs are better than the usual approach in treating this type of cancer. The usual approach is defined as care most people get for alveolar soft part sarcoma if they are not part of a clinical study, which includes treatment with rad...